期刊文献+

黏着斑激酶在肿瘤坏死因子α上调人角膜上皮细胞明胶酶活性中的作用

Effects of focal adhesional kinase signaling on TNF-α induced gelatinases activity in cornea epithelium
原文传递
导出
摘要 目的探讨黏着斑激酶(FAK)在肿瘤坏死因子α(TNF-α)上调体外培养人角膜上皮细胞明胶酶活性中的作用。方法实验研究。体外培养无眼部疾患人角膜上皮细胞,将传至3—4代的细胞暴露于含1μg/L TNF-α(B组)、10μg/LTNF—α(C组)、100μg/LTNF-α(D组)的培养基中,对照组(A组)用含等量磷酸盐缓冲液(PBS)的培养基处理,明胶酶谱分析各组条件培养基中基质金属蛋白酶2和9(MMP-2、MMP-9)的活性,免疫印迹法分析FAK总蛋白表达及磷酸化FAK的表达;运用RNA干扰技术特异性抑制人角膜上皮细胞FAK的表达并重复以上过程。统计学方法使用单因素方差分析,各组间比较采用TukeyHSD检验。结果明胶酶谱分析:与A相比,B、C、D组MMP-2、MMP-9活性均明显上调,差异有统计学意义(A、B、C、D组MMP-2活性表达分别为:124.06±4.06、146.72±5.51、241.18±5.65、389.95±4.44,F=2960.91,P=0.000;MMP-9活性表达分别为:122.78±5.86、165.70±7.90、479.49±6.22、495.88±5.03,F=4937.46,P=0.000),各组间比较差异均有统计学意义(MMP.2各组间比较均为P=0.000;MMP-9各组间比较P=0.000);免疫印迹分析:C、D组中磷酸化FAK较A组增加,差异有统计学意义(C、D组磷酸化FAK分别为:0.52±0.03、0.61±0.06;F=431.03,P=0.000),100μg/L TNF-α组较10μg/LTNF-α组中磷酸化FAK表达增加(P=0.005);运用RNA干扰技术特异性抑制人角膜上皮细胞FAK表达后,FAK总蛋白较特异性抑制之前明显下调,B、C、D组MMP-2的活性差异无统计学意义(转染后A、B、C、D组MMP-2分别为:55.13±0.66、55.67±0.43、55.49±0.20、55.91±0.37;F=2.73,P=0.079)。10、100汕g/LTNF-α干预组中MMP-9少量增加(转染后A、B、C、D组MMP-9分别为:80.48±0.39,81.26±0.62,84.43±0.47,85.56±0.61;F=105.80,P=0.000)但增加幅度较转染前明显减小,D组较C组MMP-9活性增强,差异有统计学意义(P=0.019)。仅在100μg/LTNF-α干预组中检测到FAK磷酸化(0.47±0.05),但表达量较抑制前明显减少(t=5.03,P=0.001)。结论FAK信号在TNF-α上调人角膜上皮细胞明胶酶活性过程中发挥一定作用。 Objective To investigate the effect of focal adhesional kinase (FAK) on tumor necrosis factor α (TNF-α)-induced MMP-2 and -9 activities in cornea epithelium. Methods Experimental research. The human corneal epithelial cells (HCE) were cultured in vitro. HCEs were incubated with different concentrations of TNF-α for 24 h, including 1μg/L (group B), 10μg/L (group C) and 100μg/L (group D). The control group (group A) was incubated with phosphate buffer solution. The activities of MMPs were examined by gelatin zymography and the phosphorylation of FAK was examined by western blotanalysis. FAK was down regulated by FAK siRNA following lipofectamine-mediated transfection in corneal epithelial ceils. Down-regulation was confirmed using western blot analysis. Cells cultured with different concentrations of TNF-cx ( Groups B to D) and the control group (group A) was at similar volumes of media. Then the activities of MMP-2 and -9 were examined by gelatin zymography and the phosphorylation of FAK by western blot analysis. Statistical methods adopted one-way ANOVA and Tukey's honestly significant test between each group. Results Gelatin zymography:Activities of MMP-2 and -9 in TNF-α treated groups were greater than those of the control group. The activity of MMP-2 in A, B, C and D groups was 124. 06 ± 4. 06, 146. 72 ±5.51,241.18 ±5.65 and 389.95 ±4. 44,respectively with F =2960. 91 ,P =0. 000. The activity of MMP-9 in A, B, C and D groups was 122.78 ± 5.86, 165.70 ± 7.90, 479.49 ± 6. 22 and 495.88 ± 5.03 ( F = 4937. 46, P = 0. 000 ). Significant differences were found in each two groups ( P = 0. 000). Western blot analysis:the phosphorylation of FAK (p-FAK) in test groups( 10-100 ng/ml) were significantly greater than that in control group(p-FAK of group C and D was 0. 52 ±0. 03 and 0. 61 ±0. 06, F =431.03 ,P =0. 000). p-FAK levels in 100 ng/ml group were greater than that in 10 ng/ml group(P = 0. 005 ). After down-regulating the protein FAK, TNF-α had no effect on the activity of MMP-2 ( The data of MMP-2 were 55.13 ± 0. 66, 55.67 ± 0.43,55.49 ± 0. 20 and 55.91 ± 0. 37 in groups A, B, C and D, F = 2. 73, P = 0. 079 ). We detected the increasing activity of MMP-9 in group C, D and p-FAK in group D (The data of MMP-9's activity were 80. 48±0. 39, 81.26 ±0. 62, 84. 43 ±0. 47, 85.56 ±0. 61 in groups A, B, C and D, F = 105.80, P =0. 000). The activity of MMP-9 in group D was stronger than that from the group C ( P = 0. 019 ). We just only detected a small quantity of p-FAK in group D ( 0. 47 ± 0. 05 ), which was weaker than that before down regulating the protein FAK ( t = 5.03, P = 0. 001 ). Conclusion Our results demonstrate the critical role of FAK in TNF-α induced activity of MMP-2 and -9 in human corneal epithelium cells. Blocking the FAK signaling pathway can reduce the activity of MMP-2 and -9 which may play an important role in prevention and treatment of corneal diseases.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2011年第12期1123-1128,共6页 Chinese Journal of Ophthalmology
基金 湖北省自然科学基金(2007ABA258)
关键词 黏着斑蛋白酪氨酸激酶类 肿瘤坏死因子Α 明胶酶类 上皮 角膜 RNA 小分子干扰 Focal adhesion protein-tyrosine kinases Tumor necrosis factor-alpha Gelatinases Epithelium,corheal RNA,small interfering
  • 相关文献

参考文献19

  • 1Wride MA, Geatrell J, Guggenheim JA. Proteases in eye development and disease.Birth Defects Res,2006,78:90-105.
  • 2Korpos E,Wu C,Sorokin L.Multiple roles of the extracellular matrix in inflammation.Curr Pharm Des,2009,15:1349-1357.
  • 3Yang YN, Bauer D, Wasmuth S. Matrix metalloproteinases (MMP-2 and-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and-2) during the course of experimental necrotizing herpetic keratitis.Exp Eye Res,2003,77:227-237.
  • 4Mitchell BM,Wu TG,Chong EM,et al.Expression of matrix metalloproteinases 2 and 9 in experimental comeal injury and fungal keratitis.Cornea,2007,26:589-593.
  • 5Yuan X, Mitchell BM,Wilhelmus KR. Expression of matrix metalloproteinases during experimental Candida albicans keratitis.Invest Ophthalmol Vis Sci,2009,50:737-742.
  • 6Wang L, Pan Q, Xue Q,et al. Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.Am J Vet Res,2008,69:1341-1345.
  • 7Ikema K,Matsumoto K,Inomata Y,et al.Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.Exp Eye Res,2006,83:1396-1404.
  • 8Takahashi H,Igarashi T,Fujimoto C,et al.Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo.Jpn J Ophthalmol,2007,51:3-9.
  • 9Saghizadeh M,Brown D J,Castellon R,et al.Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations.Am J Pathol,2001,158:723-734.
  • 10伍志琴,杨燕宁,邢怡桥,袁静,胡杨,曹婷,王芳,余桂香.肿瘤坏死因子-α对体外培养的兔角膜上皮细胞基质金属蛋白酶表达活性的影响[J].武汉大学学报(医学版),2009,30(5):590-594. 被引量:1

二级参考文献19

  • 1王育良,陆绵绵.中药抗单纯疱疹病毒的实验研究[J].中国中医眼科杂志,1995,5(2):78-82. 被引量:44
  • 2杨燕宁,李钫,邢怡桥,贺涛,甘晓萍.羊膜移植对实验性HSK中基质金属蛋白酶表达的影响[J].眼科研究,2006,24(3):268-271. 被引量:3
  • 3Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology[J]. Prog Retin Eye Res,2002,21(3):1-14.
  • 4Yang YN, Bauer D, Wasmuth S, et al. Matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and -2) during the course of experimental necrotizing herpetic keratitis [J]. Exp Eye Re,2003,77(2): 227-237.
  • 5Zhang H, Li C, Baciu PC. Expression of integrins and MMPs during alkaline-burn-indueed corneal angiogenesis[J]. Invest Ophthalmol Vis Sci, 2002,43 (4) : 955- 962.
  • 6Matsumoto K, Ikema K, Tanihara H. Role of cytokines and chemokines in pseudomonal keratitis[J]. Cornea, 2005, 24(8suppl):S43-S49.
  • 7Wong TT, Sethi C, Daniels JT, et al. Matrix metalloproteinases in disease and repair processes in the anteri or segment [J]. Surv Ophthalmol, 2002, 47 ( 3 ) : 239-256.
  • 8Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection [J]. Invest Ophthalmol Vis Sci, 2003,44(5) :2 020-2 025.
  • 9Barros LF, Barros PS, Ropke CD, et al. Dose-dependent in vitro inhibition of rabbit corneal matrix metallo proteinases by an extract of Pothomorphe umbellata after alkali injury[J]. Invest Ophthalmol Vis Sci, 2007, 40(8):1 129-1 132.
  • 10Stuart PM, Pan F, Yin X, et al. Effect of metalloprotease inhibitors on corneal allograft survival[J]. Invest Ophthalmol Vis Sci,2004,45(4) :1 169-1 173.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部